Compare SRRK & EPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRRK | EPR |
|---|---|---|
| Founded | 2012 | 1997 |
| Country | United States | United States |
| Employees | 289 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.4B |
| IPO Year | 2018 | N/A |
| Metric | SRRK | EPR |
|---|---|---|
| Price | $40.03 | $55.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 10 |
| Target Price | $55.10 | ★ $59.19 |
| AVG Volume (30 Days) | ★ 1.1M | 775.9K |
| Earning Date | 05-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.34% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $4.60 |
| Revenue Next Year | $449.79 | $4.05 |
| P/E Ratio | ★ N/A | $25.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.71 | $41.75 |
| 52 Week High | $49.82 | $62.08 |
| Indicator | SRRK | EPR |
|---|---|---|
| Relative Strength Index (RSI) | 32.95 | 42.92 |
| Support Level | $29.32 | $55.86 |
| Resistance Level | $42.54 | $58.33 |
| Average True Range (ATR) | 2.24 | 1.37 |
| MACD | -0.62 | -0.56 |
| Stochastic Oscillator | 1.77 | 4.35 |
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
EPR Properties is a real estate investment trust that focuses on underwriting experiential property investments on key industry and property cash flow criteria, and the credit metrics of tenants and customers. The company invests in two property segments: Experiential, including theaters, family entertainment centers, ski resorts, and other attractions; and Education, including early childhood education centers and private school properties. The Company's business is focused on Experiential real estate. The majority of revenue comes from the Experiential sector.